(2023)
Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma.
JHEP REPORTS.
5,
9
(2023)
Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B.
SCIENTIFIC REPORTS.
13,
1
(2022)
Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease.
CLINICAL AND MOLECULAR HEPATOLOGY.
28,
4
(2022)
Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY.
57,
1
(2021)
The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation-wide Cohort Study.
HEPATOLOGY.
74,
6
(2021)
Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response.
JOURNAL OF VIRAL HEPATITIS.
28,
10
(2021)
Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.
HEPATOLOGY INTERNATIONAL.
15,
4
(2021)
Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events.
DIGESTIVE DISEASES AND SCIENCES.
66,
8
(2021)
Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure.
DIGESTIVE AND LIVER DISEASE.
53,
8
(2021)
Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study.
JOURNAL OF HEPATOCELLULAR CARCINOMA.
8,
-
(2021)
Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance: potential implications for surveillance goal.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY.
56,
3
(2021)
A comparison of factors associated with the temporal improvement in the overall survival of BCLC stage 0 hepatocellular carcinoma patients.
DIGESTIVE AND LIVER DISEASE.
53,
2
(2021)
Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea.
LIVER CANCER.
10,
1
(2021)
Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study.
DIGESTIVE DISEASES AND SCIENCES.
66,
1
(2021)
Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY.
12,
1
(2021)
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma.
YONSEI MEDICAL JOURNAL.
62,
1
(2020)
Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria.
ANNALS OF SURGICAL TREATMENT AND RESEARCH.
99,
4
(2020)
Advanced Stage Hepatocellular Carcinoma Successfully Treated with Transarterial Radioembolization and Multi-tyrosine Kinase Inhibitor Therapy.
Journal of Liver Cancer.
20,
2
(2020)
Long-term hepatitis B surface antigen (HBsAg) kinetics during entecavir treatment in Korean patients-Functional cure unlikely.
JOURNAL OF VIRAL HEPATITIS.
27,
9
학술회의논문
(2017)
Clinical Characteristics, Potencial Etiology and Mode of Detection for Non-B Non-C Hepatocellular Carcinoma in Korea.
KDDW 2017.
대한민국
(2017)
Comparison of Treatment Efficacy between Entecavir (ETV) and Tenofovir Disoproxil Fumarate (TDF) in Treatment-naive Chronic Hepatitis B Patients: Long-term Real-world Experience.
KDDW 2017.
대한민국
(2015)
Locoregional therapy or liver transplantation forhepatocellular carcinoma fulfilling the Milan criteria.
대한소화기학회.
대한민국
(2015)
Cytotoxic synergy between sorafenib and cyclooxygenase 2 inhibitor celecoxib in vitro: induction of cell death of hepatocellular carcinoma through ER stress mediated apoptosis.
AASLD.
미국
(2015)
Discontinuation of Antiviral prophylaxis in Hepatitis B Virus Infected Patients Who Received Cytotoxic Chemotherapy: Outcomes and Predictors.
AASLD.
미국
(2015)
Survival of hepatocellular carcinoma patients according to recommended treatment by the Barcelona Clinic Liver Cancer or Hong Kong Liver Cancer staging system in hepatitis B endemic area.
AASLD.
미국
(2015)
Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels..
AASLD.
미국
(2015)
Lamivudine vs. Entecavir for the newly diagnosed hepatitis B-virus related Hepatocellular carcinoma.
AASLD.
미국
(2015)
Survival and prognostic factors in patients with intermediate stage hepatocellular carcinoma (HCC) who were treated with repeated transarterial chemoembolization (TACE).
AASLD.
미국
(2015)
Cause of death in patients with hepatocellular carcinoma within the Milan criteria.
대한간암학회.
대한민국
(2015)
Effect of Oral Antiviral Treatment on Long-Term Outcomes of Radiofrequency Ablation Therapy for Hepatitis B Virus-Related Hepatocellular Carcinoma.
대한간암학회.
대한민국
(2015)
Hwpatocellular Carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low trial load.
대한간암학회.
대한민국
(2014)
Differential roles of non-receptor tyrosine kinase fak family members in TGF-β-mediated fibrogenic signaling in hepatic stellate cells.
AASLD.
미국
(2014)
Effect of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
AASLD.
미국
(2014)
HBV DNA / Quantitative HBsAg level ratio, but not either quantitative HBsAg level or HBV DNA, can predict hepatocellular carcinoma development in HBsAg-nagative chronic hepatitis patients with HBV DNA ≥2000 IU/ml.
AASLD.
미국
(2014)
Risk of development of hepatocellular carcinoma in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferse levels.
AASLD.
미국
(2014)
The importance of intrahepatic tumor in hepatocellular carcinoma with extrahepatic spread in patients treated with sorafenib.
AASLD.
미국
(2014)
Clinical characteristics and outcomes of hepatocellular carcinoma in korea: results from random sample adult of statutory nation-wide cancer registry, 2008-2010.
ILCA.
일본
(2014)
Predictive factor of hepatocellular carcinoma in hbeag-negative chronic hepatitis patients: comparison of hbv dna/quantitative hbsag level ratio with quantitative hbsag level and hbv dna.
ILCA.
일본
(2014)
Sorafenib Therapy In hcc patients with extrahepatic spread: Treatment efficacy and prognostic factors.
ILCA.
일본
